Through bioinformatic analysis and verified experiments, we focused on miR-483-3p as a possible target microRNA of metformin and an upstream microRNA of METTL3, suggesting that metformin inhibited the proliferation of breast cancer cells by the miR-483-3p/METTL3 pathway. The gene discussed is METTL3; the disease is breast carcinoma.